Evidence map›Paper›PMID 31272443›Full record

ArticleBMC medical ethics2019

Trust and the ethical challenges in the use of whole genome sequencing for tuberculosis surveillance: a qualitative study of stakeholder perspectives.

Carly Jackson, Jennifer L Gardy, Hedieh C Shadiloo, Diego S Silva

Open access · goldAbstract read
In one paragraph

Article in BMC medical ethics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. "ItResearch ethics · 2025
    Article
  5. Article
  6. Article
  7. Rapid Bioethical Assessment forEthiopian journal of health sciences · 2023
    Article
  8. Article
  9. Article
  10. The New Precision Stewards?Journal of personalized medicine · 2022
    Article
  11. Review
  12. Article
  13. Advancing TB research using digitized programmatic data.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2021
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Digital microbiology.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2020
    Review
  19. Article
  20. Bacterial Vaginosis: Current Diagnostic Avenues and Future Opportunities.Frontiers in cellular and infection microbiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Carly JacksonFaculty of Health Sciences, Simon Fraser University, BLU 11300 - 8888 University Drive, Burnaby, BC, V5A 1S6, Canada.
Jennifer L GardyBritish Columbia Centre for Disease Control, Vancouver, BC, Canada.
Hedieh C ShadilooFaculty of Health Sciences, Simon Fraser University, BLU 11300 - 8888 University Drive, Burnaby, BC, V5A 1S6, Canada.
Diego S SilvaFaculty of Health Sciences, Simon Fraser University, BLU 11300 - 8888 University Drive, Burnaby, BC, V5A 1S6, Canada. dsilva@sfu.ca.ORCID 0000-0002-8195-6404
Simon Fraser University · CAThe University of Sydney · AUUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEmerging genomic technologies promise more efficient infectious disease control. Whole genome sequencing (WGS) is increasingly being used in tuberculosis (TB) diagnosis, surveillance, and epidemiology. However, while the use of WGS by public health agencies may raise ethical, legal, and socio-political concerns, these challenges are poorly understood.

methodBetween November 2017 and April 2018, we conducted semi-structured interviews with 22 key stakeholders across the fields of governance and policy, public health, and laboratory sciences representing the major jurisdictions currently using WGS in national TB programs. Thematic analysis of the interviews was conducted using NVivo 11.

resultsRespondents identified several ethical and practical challenges associated with WGS in TB care and surveillance, all related to issues of trust, including: 1) the power of public health; 2) data sharing and profits derived from surveillance efforts; and 3) concerns regarding who has access to, and can benefit from, the technology. Additional challenges included: the potential utility that WGS adds to a public health program, the risks associated with linking necessary epidemiological metadata to the genomic data, and challenges associated with jurisdictional capacity to implement the technology.

conclusionsSuccessful implementation of WGS is dependent on fostering relationships of trust between those working with genomics technology and those directly impacted by it, including clinicians. Building trust (a) between the public and the public health agencies and (b) within public health agencies themselves is critical due to the inherent complexity of WGS and its implementation for communicable disease control purposes.

Indexed as

Population SurveillanceTrustAttitude of Health PersonnelHumansInformation DisseminationInterviews as TopicTuberculosis, PulmonaryWhole Genome SequencingEmpirical ethicsQualitativeSurveillanceTrustTuberculosisWhole genome sequencing

Identifiers

PMID31272443
PMCPMC6610958
OpenAlexW2953855402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.